412 Search Results for Diabetes
Because of their cardiovascular protective effects, SGLT2 inhibitors have been a game-changer in Type 2 diabetes treatment. That is especially the case, now that the FDA has approved a new indication for canagliflozin to reduce... View Article
Results of a range of studies are conclusive: Continuous glucose monitoring can improve glycemic control and reduce hypoglycemia risks in patients with both Type 1 and Type 2 diabetes. Now, the Defense Health Agency, which... View Article
ATLANTA—How does a diagnosis of diabetes affect weight management among U.S. veterans? A study in the journal Obesity (Silver Spring) sought to assess weight trends and diabetes prevalence among U.S. veterans.1 Atlanta VAMC researchers and... View Article
SAN DIEGO—When service members leave active duty and receive healthcare in a different setting, care for conditions such as diabetes can suffer. A study in Military Medicine pointed out that changes in healthcare have been... View Article
DURHAM, NC—So-called physician extenders do as good a job as physicians at the VA in helping to achieve good outcomes in diabetes patients, according to a new study. The report in Annals of Internal Medicine... View Article
Veterans on Standard Diabetes Care Face Dangers from Hypoglycemia Subhead: Post-hoc VADT Analysis Links Low Blood Sugar to CV Events
BALTIMORE, MD—A post-hoc analysis of the Veterans Affairs Diabetes Trial (VADT) once again shines a spotlight on the dangers of hypoglycemia in veterans treated for Type 2 diabetes. The study published in Diabetes Care found... View Article
VA clinicians should exercise caution with use of sulfonylurea in some patients with co-morbid type 2 diabetes and cardiovascular disease, according to new research.
How important is adherence to oral medications in reducing complications for veterans with diabetes?
Air pollution, even at levels technically falling into safe ranges, are associated with an increased risk of diabetes, according to a new study involving VA researchers.
In a significant change, the American Diabetes Association’s 2018 guidelines advocate use of a glucose-lowering agent with proven cardiovascular benefit or mortality reduction in patients with Type 2 diabetes mellitus (T2DM) and co-morbid cardiovascular disease.
Overall prevalence of diabetes was 20% for the general U.S. population but nearly 25% for veterans, according to a recent study using data from the National Health and Nutrition Examination Survey (NHANES).
Recent clinical studies have documented why continuous glucose monitors (CGM) can offer significant benefits to patients diagnosed with diabetes.
Having Type 2 diabetes mellitus (DM-2) increases mortality risk in breast cancer patients, regardless of whether diabetes was diagnosed before or after breast cancer, according to a recent study.
About 5% of the United States population has been diagnosed with type 1 diabetes, and the great majority are diagnosed before age 25. Since a diabetes diagnosis prevents enlistment in the military, relatively few veterans have the condition compared to type 2 diabetes, which affects about a fourth of VHA patients.
OKLAHOMA CITY — While multiple sclerosis (MS) itself remains incurable, development of more effective treatments over the past 25 years has increased life expectancy for patients with the disease. Today, MS patients have a life expectancy only about seven years less than individuals without the disease, according to the National Multiple Sclerosis Society.
LOUIS—For years, research has shown that patients with diabetes have an increased risk of kidney disease. But what about the reverse? A new study published in the journal Kidney International provides evidence that kidney dysfunction... View Article
PORTLAND, OR—Hepatitis C virus (HCV) infection is linked to diabetes and often worsens glycemic control in patients with diabetes. A study published in Diabetes Care investigated whether eradication of HCV infection with direct-acting antiviral (DAAs)... View Article
It’s not only the VA that struggles with the balance between just enough treatment of older Type 2 diabetes patients and too much.
Diabetes Guidelines Don’t Include Specific Pharmacotherapy Advise By Annette M. Boyle WASHINGTON —The VA and DoD Evidence-Based Practice Work Group has recently released five updated clinical practice guidelines. They cover common conditions such as Type... View Article
How diabetes affects pathophysiological processes among patients with acute heart failure (AHF) is unclear, according to a new study published in the European Journal of Heart Failure.1